NCI centers improve outcomes in pancreatic cancer surgery
NCI-designated cancer centers lead to better surgical options and survival rates for patients with pancreatic ductal adenocarcinoma (PDAC).
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
Advancements in Biliary Tract Cancer Therapies
Biliary tract cancers are now seeing transformative therapies that enhance patient outcomes.
Rising Liver Cancer Rates Demand Surgical Vigilance
Primary liver cancer cases are increasing rapidly, demanding enhanced screening and surgical readiness.
Neoadjuvant Strategies Yield Similar Results in Pancreatic Cancer
A meta-analysis finds that neoadjuvant chemoradiotherapy and chemotherapy have comparable outcomes for pancreatic ductal adenocarcinoma.
Urine DNA Enhances Diagnosis of IPMN
A new study shows urine cell-free DNA can aid in diagnosing intraductal papillary mucinous neoplasms (IPMN), which may improve patient management.
Resecting Colorectal Liver Metastases in Progressive Disease Improves Survival
Surgery for colorectal liver metastases after chemotherapy failure can offer survival benefits.
Robotic Resection Works for Large Central Hepatic Tumors
Robotic liver surgery proves effective for complex resections of benign liver tumors like focal nodular hyperplasia.
Navigating Evidence for Post-Pancreatoduodenectomy Fistulas
Surgeons need to balance level 1 evidence and experiential insight in mitigating pancreatic fistulas after pancreatoduodenectomy.
Radical Resection with Intestinal Autotransplantation Improves Outcomes in Pancreatic Cancer
Surgeons treating locally advanced pancreatic cancer (LAPC) can improve patient survival by using radical resection combined with intestinal autotransplantation after systemic treatment.
Medicaid Expansion Lowers Death Rate in Colorectal Cancer Patients
Medicaid expansion is linked to improved survival rates in younger colorectal cancer patients with liver metastasis, impacting surgical decision-making.